NL7704126A - Werkwijze voor het bepalen van een aminoglyco- side antibioticum en daartoe geschikte inrich- ting. - Google Patents

Werkwijze voor het bepalen van een aminoglyco- side antibioticum en daartoe geschikte inrich- ting.

Info

Publication number
NL7704126A
NL7704126A NL7704126A NL7704126A NL7704126A NL 7704126 A NL7704126 A NL 7704126A NL 7704126 A NL7704126 A NL 7704126A NL 7704126 A NL7704126 A NL 7704126A NL 7704126 A NL7704126 A NL 7704126A
Authority
NL
Netherlands
Prior art keywords
aminoglyco
determining
suitable device
side antibiotic
antibiotic
Prior art date
Application number
NL7704126A
Other languages
English (en)
Dutch (nl)
Original Assignee
Technicon Instr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technicon Instr filed Critical Technicon Instr
Publication of NL7704126A publication Critical patent/NL7704126A/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/80Fluorescent dyes, e.g. rhodamine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NL7704126A 1976-04-15 1977-04-15 Werkwijze voor het bepalen van een aminoglyco- side antibioticum en daartoe geschikte inrich- ting. NL7704126A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB15736/76A GB1573212A (en) 1976-04-15 1976-04-15 Immunoassay for gentamicin

Publications (1)

Publication Number Publication Date
NL7704126A true NL7704126A (nl) 1977-10-18

Family

ID=10064574

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7704126A NL7704126A (nl) 1976-04-15 1977-04-15 Werkwijze voor het bepalen van een aminoglyco- side antibioticum en daartoe geschikte inrich- ting.

Country Status (8)

Country Link
US (1) US4150949A (OSRAM)
JP (1) JPS5338619A (OSRAM)
CA (1) CA1073813A (OSRAM)
DE (1) DE2716276A1 (OSRAM)
FR (1) FR2348492A1 (OSRAM)
GB (1) GB1573212A (OSRAM)
NL (1) NL7704126A (OSRAM)
SE (1) SE442679B (OSRAM)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53134647A (en) * 1978-04-01 1978-11-24 Iseki Agricult Mach Threshing device
US4238195A (en) 1979-01-18 1980-12-09 Miles Laboratories, Inc. Fluorescer-labeled specific binding assays
FR2452704A1 (fr) * 1979-03-27 1980-10-24 Anvar Nouveau procede de dosage des aminoglycosides et reactifs pour la mise en oeuvre de ce procede
US4271123A (en) * 1979-10-22 1981-06-02 Bio-Rad Laboratories, Inc. Automated system for performing fluorescent immunoassays
US4401764A (en) * 1980-02-07 1983-08-30 Technicon Instruments Corporation Immunoassays employing labeled reagent and a conjugate having two binding sites
US4293310A (en) * 1980-03-14 1981-10-06 University Of Pittsburgh Photoelectrochemical immunoassay
EP0047459B1 (de) * 1980-09-08 1984-11-21 International Diagnostic Technology, Inc. Fluoreszierendes Reagenz und Immunofluoreszenz-Bestimmungsmethode
US4652531A (en) * 1981-03-03 1987-03-24 Syntex (U.S.A.) Inc. Fluorescent protein binding assays with unsymmetrical fluorescein derivatives
US4604365A (en) * 1981-06-02 1986-08-05 Electro-Nucleonics, Inc. Immunoprecipitation assay
EP0079962B1 (en) * 1981-06-02 1985-08-28 Electro-Nucleonics, Inc. Immunoprecipitation assay
JPS5977356A (ja) 1982-06-30 1984-05-02 Fuji Photo Film Co Ltd 螢光アツセイ用多層分析要素およびそれを用いる螢光アツセイ法
US4707441A (en) * 1984-08-06 1987-11-17 Technicon Instruments Corp. Binding assays in automated apparatus with liposome compatible surfactants
JPS6451515U (OSRAM) * 1987-09-28 1989-03-30
AU2002239721C1 (en) * 2000-12-22 2008-04-24 Medlyte, Inc. Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
US20040171062A1 (en) * 2002-02-28 2004-09-02 Plexxikon, Inc. Methods for the design of molecular scaffolds and ligands
AU2003272548A1 (en) * 2002-09-16 2004-04-30 Plexxikon, Inc. Crystal structure of pim-1 kinase
EP1627045A2 (en) * 2003-02-28 2006-02-22 Plexxikon, Inc. Pyk2 crystal structure and uses
US20050079548A1 (en) * 2003-07-07 2005-04-14 Plexxikon, Inc. Ligand development using PDE4B crystal structures
US7348338B2 (en) * 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
DK1648867T3 (da) * 2003-07-17 2013-12-16 Plexxikon Inc Ppar-aktive forbindelser
WO2005028624A2 (en) * 2003-09-15 2005-03-31 Plexxikon, Inc. Molecular scaffolds for kinase ligand development
CA2539452C (en) * 2003-09-17 2013-10-29 Guava Technologies, Inc. Compositions and methods for analysis of target analytes
US20070066641A1 (en) * 2003-12-19 2007-03-22 Prabha Ibrahim Compounds and methods for development of RET modulators
PL1696920T3 (pl) 2003-12-19 2015-03-31 Plexxikon Inc Związki i sposoby opracowywania modulatorów Ret
US7794713B2 (en) * 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
CA2565965A1 (en) 2004-05-06 2006-07-27 Plexxikon, Inc. Pde4b inhibitors and uses therefor
US20060058339A1 (en) * 2004-06-17 2006-03-16 Ibrahim Prabha N Compounds modulating c-kit activity and uses therefor
US7498342B2 (en) * 2004-06-17 2009-03-03 Plexxikon, Inc. Compounds modulating c-kit activity
CA2583428A1 (en) * 2004-09-03 2006-03-09 Plexxikon, Inc. Bicyclic heteroaryl pde4b inhibitors
JP2008521829A (ja) * 2004-11-30 2008-06-26 プレキシコン,インコーポレーテッド Ppar活性化合物
US7846941B2 (en) * 2005-05-17 2010-12-07 Plexxikon, Inc. Compounds modulating c-kit and c-fms activity and uses therefor
MX2007016463A (es) 2005-06-22 2008-03-04 Plexxikon Inc Derivados de pirrolo [2,3-b] piridina como inhibidores de proteina cinasa.
KR20080047591A (ko) * 2005-09-07 2008-05-29 플렉시콘, 인코퍼레이티드 Ppar 조절인자로서 사용하기 위한 1,3-이치환된 인돌유도체
US20090074720A1 (en) * 2005-10-28 2009-03-19 Sabbadini Roger A Methods for decreasing immune response and treating immune conditions
US20080213274A1 (en) * 2005-10-28 2008-09-04 Sabbadini Roger A Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye
US9274129B2 (en) * 2006-05-31 2016-03-01 Lpath, Inc. Methods and reagents for detecting bioactive lipids
US8796429B2 (en) * 2006-05-31 2014-08-05 Lpath, Inc. Bioactive lipid derivatives, and methods of making and using same
US7862812B2 (en) * 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
US9274130B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Prevention and treatment of pain using antibodies to lysophosphatidic acid
US20080138334A1 (en) * 2006-05-31 2008-06-12 Sabbadini Roger A Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same
AU2007313822A1 (en) * 2006-10-27 2008-05-08 Lpath, Inc. Compositions and methods for treating ocular diseases and conditions
DK2087002T3 (da) 2006-10-27 2014-10-27 Lpath Inc Sammensætninger og fremgangsmåder til binding af sphingosin-1-phosphat
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US7872018B2 (en) 2006-12-21 2011-01-18 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
PE20121126A1 (es) * 2006-12-21 2012-08-24 Plexxikon Inc Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
WO2008079909A1 (en) * 2006-12-21 2008-07-03 Plexxikon, Inc. Pyrrolo [2,3-b] pyridines as kinase modulators
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
AU2008276063B2 (en) 2007-07-17 2013-11-28 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US8361465B2 (en) * 2007-10-26 2013-01-29 Lpath, Inc. Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
US8871202B2 (en) 2008-10-24 2014-10-28 Lpath, Inc. Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
BRPI1008709B8 (pt) * 2009-04-03 2021-05-25 Hoffmann La Roche dispersão sólida, formulação, composição e comprimido compreendendo {3-[5-(4-cloro-fenil)-1h-pirrol[2,3-b]piridina-3-carbonil]-2,4-diflúor-fenil}-amida do ácido propano-1-sulfônico
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
US20110112127A1 (en) 2009-11-06 2011-05-12 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
MY162950A (en) 2011-02-07 2017-07-31 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
AR085279A1 (es) 2011-02-21 2013-09-18 Plexxikon Inc Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
JP6113151B2 (ja) 2011-05-17 2017-04-12 プレキシコン インコーポレーテッドPlexxikon Inc. キナーゼ調節およびその適応症
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
CN103509068B (zh) * 2012-06-19 2017-07-21 北京勤邦生物技术有限公司 丁胺卡那霉素半抗原及其制备方法和应用
CN104568925A (zh) * 2014-12-30 2015-04-29 中国农业科学院农产品加工研究所 一种硫酸链霉素的检测方法
WO2016164641A1 (en) 2015-04-08 2016-10-13 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US10829484B2 (en) 2015-07-28 2020-11-10 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
AU2016367147B2 (en) 2015-12-07 2021-04-08 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
TW201815766A (zh) 2016-09-22 2018-05-01 美商普雷辛肯公司 用於ido及tdo調節之化合物及方法以及其適應症
AU2017395023B2 (en) 2016-12-23 2022-04-07 Plexxikon Inc. Compounds and methods for CDK8 modulation and indications therefor
US10428067B2 (en) 2017-06-07 2019-10-01 Plexxikon Inc. Compounds and methods for kinase modulation
EP3953351A1 (en) 2019-04-09 2022-02-16 Plexxikon Inc. Condensed azines for ep300 or cbp modulation and indications therefor
US12509444B2 (en) 2019-12-06 2025-12-30 Plexxikon Inc. Compounds and methods for CD73 modulation and indications therefor
TW202204354A (zh) 2020-04-02 2022-02-01 美商普雷辛肯公司 用於csk調節之化合物及方法以及其說明
AU2021261383A1 (en) 2020-04-23 2022-11-17 Opna Bio SA Compounds and methods for CD73 modulation and indications therefor
US20230081426A1 (en) 2020-09-18 2023-03-16 Plexxikon Inc. Compounds and methods for kras modulation and indications therefor
WO2022240966A1 (en) 2021-05-11 2022-11-17 Opna Immuno-Oncology Sa Compounds and methods for yap/tead modulation and indications therefor
US20240132521A1 (en) 2022-08-22 2024-04-25 Iambic Therapeutics, Inc. Compounds and methods for modulating her2

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2797149A (en) * 1953-01-08 1957-06-25 Technicon International Ltd Methods of and apparatus for analyzing liquids containing crystalloid and non-crystalloid constituents
US3399972A (en) * 1964-08-24 1968-09-03 Technicon Corp Chromatography analysis apparatus and method
US3789116A (en) * 1970-12-09 1974-01-29 Abbott Lab Fluorescent labeled antibody reagent
US3901654A (en) * 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3812181A (en) * 1971-12-27 1974-05-21 Hoffmann La Roche O-(alpha-hydroxycinnamoyl)benzoic acid and related compounds
AU473159B2 (en) * 1973-03-05 1976-06-17 F. Hoffmann-Laroche & Co. Aktiengesellschaft Furanone derivatives useful in fluorometry
US3998943A (en) * 1973-10-02 1976-12-21 Syva Company Double receptor fluorescent immunoassay
US3935074A (en) * 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US3992516A (en) * 1974-10-30 1976-11-16 Sook Kyung Lim Direct fluorescent antibody composition and method for P. Pneumocystis carinii
US4018884A (en) * 1975-06-26 1977-04-19 Hoffmann-La Roche Inc. Fluorogenic materials and labeling techniques
US4036946A (en) * 1975-10-20 1977-07-19 Marcos Kleinerman Immunofluorometric method for measuring minute quantities of antigens, antibodies and other substances

Also Published As

Publication number Publication date
FR2348492B1 (OSRAM) 1983-10-21
SE7704244L (sv) 1977-10-16
US4150949A (en) 1979-04-24
JPS6139623B2 (OSRAM) 1986-09-04
JPS5338619A (en) 1978-04-08
SE442679B (sv) 1986-01-20
CA1073813A (en) 1980-03-18
FR2348492A1 (fr) 1977-11-10
DE2716276C2 (OSRAM) 1987-11-19
GB1573212A (en) 1980-08-20
DE2716276A1 (de) 1977-10-27

Similar Documents

Publication Publication Date Title
NL7704126A (nl) Werkwijze voor het bepalen van een aminoglyco- side antibioticum en daartoe geschikte inrich- ting.
NL7702647A (nl) Analyse-inrichting en werkwijze voor het analy- seren.
NL7703591A (nl) Werkwijze en inrichting voor het bekleden van onderdelen.
NL7703169A (nl) Werkwijze en inrichting voor wijziging van een video signaal.
NL7608736A (nl) Werkwijze en inrichting voor het maken van een tomogram.
NL7708499A (nl) Werkwijze en inrichting voor het invoeren van een adressignaal in een videosignaal.
NL186984C (nl) Werkwijze voor het vervaardigen van een transistorinrichting.
NL7700521A (nl) Werkwijze voor het vervaardigen van een con- servenblik en inrichting voor de uitvoering van deze werkwijze.
NL7710897A (nl) Werkwijze en inrichting voor het oprichten van koepelvormige bouwconstructies.
NL7805031A (nl) Werkwijze en inrichting voor het vervaardigen van beeldcombinaties.
NL7611278A (nl) Werkwijze en inrichting voor het afsluiten van een pijpleiding.
NL7712043A (nl) Werkwijze en inrichting voor het controleren van bankbiljetten.
NL7711587A (nl) Werkwijze en inrichting voor het begassen van een vloeistof.
NL7708508A (nl) Inrichting voor het onderscheiden van deeltjes en werkwijze voor het onderscheiden van deeltjes.
NL7801832A (nl) Werkwijze en inrichting voor het scheiden van stoffen.
NL7711457A (nl) Werkwijze en inrichting voor het omwikkelen van een voorwerp.
NL7705681A (nl) Werkwijze en inrichting voor het bekleden van een axiaal bewegend buisvormig voorwerp.
NL7802828A (nl) Werkwijze en inrichting voor het dopen van halfgeleidermaterialen.
NL7700074A (nl) Inrichting voor het pneumatisch meenemen van een sonde.
NL7711080A (nl) Draaibare vorminrichting en werkwijze voor het draaiend vormen.
NL7707299A (nl) Werkwijze en inrichting voor het vormen van een inwendige, rondlopende groef in een kunststof- buisdeel.
NL7706267A (nl) Werkwijze en inrichting voor het testen van transmissielijnen.
NL7703992A (nl) Werkwijze voor het verkrijgen van een homogeen chemisch-reaktief systeem en inrichting voor het uitvoeren van deze werkwijze.
NL7711355A (nl) Inrichting en werkwijze voor het aanvatten van een zak.
NL7711844A (nl) Werkwijze en inrichting voor het invoegen van een adressignaal in een videosignaal.

Legal Events

Date Code Title Description
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed